高级检索
崔为国, 胡清海, 李宏, 朱新朋, 孙国清, 田随安, 刘春华, 曹广华, 范二军, 张旻. 河南省抗HIV治疗效果及耐药变异分析[J]. 中国公共卫生, 2009, 25(10): 1218-1219. DOI: 10.11847/zgggws2009-25-10-35
引用本文: 崔为国, 胡清海, 李宏, 朱新朋, 孙国清, 田随安, 刘春华, 曹广华, 范二军, 张旻. 河南省抗HIV治疗效果及耐药变异分析[J]. 中国公共卫生, 2009, 25(10): 1218-1219. DOI: 10.11847/zgggws2009-25-10-35
CUI Wei-guo, HU Qing-hai, LI Hong, . Efficacy of anti-HIV treatment and drug-resistance mutations in Henan province, China[J]. Chinese Journal of Public Health, 2009, 25(10): 1218-1219. DOI: 10.11847/zgggws2009-25-10-35
Citation: CUI Wei-guo, HU Qing-hai, LI Hong, . Efficacy of anti-HIV treatment and drug-resistance mutations in Henan province, China[J]. Chinese Journal of Public Health, 2009, 25(10): 1218-1219. DOI: 10.11847/zgggws2009-25-10-35

河南省抗HIV治疗效果及耐药变异分析

Efficacy of anti-HIV treatment and drug-resistance mutations in Henan province, China

  • 摘要: 目的研究河南省人类免疫缺陷病毒/艾滋病(HIV/AIDS)患者应用高效抗逆转录病毒治疗后治疗效果及耐药变异产生情况。方法对采用2种治疗方案的河南省HIV/AIDS患者进行病毒载量、CD4+T淋巴细胞数、耐药变异基因型监测。结果2种治疗方案都在部分HIV/AIDS患者身上取得病毒载量抑制和提升CD4+T淋巴细胞数效果,但用药后均有耐药变异发生,2005年D4T/ddI/NVP、AZT/ddI/NVP高度耐药相关突变率分别为19.7%,16.2%;2006年分别为19.4%,19.5%。结论河南省HIV/AIDS患者应用高效抗逆转录病毒治疗(HAART)治疗基本上取得了预期的疗效,但在应用逆转录酶抑制剂后有耐药变异发生,且多为交叉耐药、多药耐药。所以应用逆转录酶抑制剂时要加强耐药监测,规范管理,及时调查用药以节省有限的药物资源并防止耐药株的产生。

     

    Abstract: ObjectiveTo study the virological and inmunological effcacy of HAART among Chinese HIV/ASS patients and its influence of drug resistance mutations.MethodsViral load, CD4+ Tlymphocytes count and drug resistance genotype were detected in patients after two reginens treatment.ResultsUndetectable viral load level and CD4+ Tbmphocytes maintenance were achieved among a part of HIV/AIDS patients, but drug resistance mutations happened during the two reginens.High drug resistance mutation rates of D4T/ddI/NVP, AZT/ddI/NVP were 19.7%,16.2% in 2005, and 19.4%,19.5% in 2006.ConclusionExpected efficacy was achieved in Chinese HIV/ASS patients But the high prevalence of drug resistance mutations against reverse transcriptase inhibitors, crossing drug resistance, and multi-drug resistance suggest that more attention should be paid to the drug resistance mutation detection, treatment standardization.

     

/

返回文章
返回